Cargando…
Hypothesis on Serenoa repens (Bartram) small extract inhibition of prostatic 5α-reductase through an in silico approach on 5β-reductase x-ray structure
Benign prostatic hyperplasia is a common disease in men aged over 50 years old, with an incidence increasing to more than 80% over the age of 70, that is increasingly going to attract pharmaceutical interest. Within conventional therapies, such as α-adrenoreceptor antagonists and 5α-reductase inhibi...
Autores principales: | Governa, Paolo, Giachetti, Daniela, Biagi, Marco, Manetti, Fabrizio, De Vico, Luca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5126621/ https://www.ncbi.nlm.nih.gov/pubmed/27904805 http://dx.doi.org/10.7717/peerj.2698 |
Ejemplares similares
-
Is Serenoa repens Effective in the Treatment of Benign Prostatic Hyperplasia?
por: Çeker, Gökhan
Publicado: (2020) -
Exploring with the Bartrams,
por: Sutton, Ann, 1923-
Publicado: (1963) -
Serenoa Repens: Does It have Any Role in the Management of Androgenetic Alopecia?
por: Murugusundram, Sundaram
Publicado: (2009) -
Hexanic Extract of Serenoa repens (Permixon(®)): A Review in Symptomatic Benign Prostatic Hyperplasia
por: Blair, Hannah A.
Publicado: (2022) -
A substitute variety for agronomically and medicinally important Serenoa repens (saw palmetto)
por: Jaiswal, Yogini, et al.
Publicado: (2019)